Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorFrench Africa Pediatric Oncology Group

About this trial

As the survival of children with retinoblastoma in high income countries is higher than 95% including the bilateral forms this study hopes to improve the outcome in low income countries in Africa by improving early diagnosis and early implementation of this protocol of therapeutic recommendations for treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Unilateral intraocular Retinoblastoma (RB)

Unilateral extraocular intraorbital (RB)

Bilateral intraocular (RB)

bilateral intraocular (RB) on one side and extraocular but intraorbital on the other side.

Disqualifiers

Externalized tumor mass

massive extension to optic nerve up to optical channeltumor

intracranial extension leptomeninges

cerebral parenchyma

Trial population

all children presenting at participating units who can be treated

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • OBSERVATIONAL

    Other intervention

    We will look at the outcome of the the children treated to see if the survival is improved when these therapeutic measures are followed.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Number of cases with retinoblastoma in each participating hospital.

Evaluation of the number of cases registered .

Time frame
10 years
2

Number of cases with stage 2 disease

Evaluation of the number of cases registered with stage 2 disease.

Time frame
10 years
3

Feasibility of these therapeutic recommendations in an African setting

Evaluate the application of these therapeutic recommendations

Time frame
10 years
4

Evaluating the treatment given.

Comparison of treatment given and recommended treatment.

Time frame
10 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.